
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

69973
10.1038/s41598-024-69973-5
Article
The neuroscience of itch in relation to transdiagnostic psychological approaches
https://orcid.org/0000-0001-8584-1738
Kim Jeffrey J. jeffrey.kim@uqconnect.edu.au

123
https://orcid.org/0000-0003-1967-4884
Day Melissa A. 14
1 https://ror.org/00rqy9422 grid.1003.2 0000 0000 9320 7537 School of Psychology, The University of Queensland, St Lucia, Australia
2 https://ror.org/00rqy9422 grid.1003.2 0000 0000 9320 7537 Centre for Advanced Imaging, The University of Queensland, St Lucia, Australia
3 https://ror.org/05p52kj31 grid.416100.2 0000 0001 0688 4634 Clinical Skills Development Service, Royal Brisbane & Women’s Hospital, Herston, Australia
4 grid.34477.33 0000000122986657 Department of Rehabilitation Medicine, The University of Washington, Seattle, USA
14 9 2024
14 9 2024
2024
14 2147629 4 2023
12 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The experience of itch and its associated chronic conditions (i.e., atopic dermatitis) form a significant burden of disease. Knowledge of how the brain processes itch, that might occur uniquely for chronic itch populations, could be used to guide more effective psychotherapeutic interventions for these groups. To build the evidence base for such approaches, we conducted a series of coordinates-based fMRI analyses, to identify the shared neural mechanisms for itch across the published literature. Upon so doing, we identified a core “itch network” that spans the Basal Ganglia/Thalamus, Claustrum and Insula. Additionally, we found evidence that the Paracentral Lobule and Medial Frontal Gyrus, regions associated with cognitive control and response inhibition, deactivate during itch. Interestingly, a separate analysis for chronic itch populations identified significant recruitment of the Left Paracentral Lobule, potentially suggesting the recruitment of cognitive control mechanisms to resist the urge to scratch. We position these results in light of further integrative studies that could use neuroimaging alongside clinical studies, to explore how transdiagnostic psychological approaches—such as mindfulness and compassion training—might help to improve quality of life for individuals who experience chronic itch.

Keywords

Itch
Mindfulness
Compassion
CBT
fMRI
Subject terms

Psychology
Skin diseases
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

The skin is the largest physical organ of the human body, and represents a complex immunological environment which responds to pathogens as well as provides protection from physical insult and injury1. In order to remove pathogens from the surface of the skin, itch is an evolved mechanism which creates an urge to scratch1–3. Although itch is a normal response in most circumstances, it is pernicious in numerous clinical conditions, such as atopic dermatitis and psoriasis4,5, as well as maladaptive in major burn injuries, such as when itch arises around the burn, graft or donor site during the skin’s healing process6, or during phantom limb amputation7.

Previous work has outlined the immunological and neurophysiological mechanisms of itch3,8; however, this research has typically been conducted in model organisms8–10. In humans, individual studies have recently begun to examine the neural correlates of itch using techniques such as fMRI. Initial evidence has posited the recruitment of the insula, cingulate and prefrontal cortices as markers of acute itch, as well as ipsilateral motor cortices, potentially in the context of a planned scratch response11. Furthermore, research has also implicated reward circuitry, such as the striatum and midbrain, as important in the context of pleasurable sensations evoked from scratching an itch12. Whilst insightful, lacking to date is an understanding of the replicated brain regions and networks, reliably associated with itch as reported within individual neuroimaging studies. Identification of replicable mechanisms can afford the capacity to identify how neural markers of itch may be unique to certain clinical populations, such as those with atopic dermatitis and/or psoriasis1,9.

In order to assess these possibilities, we conducted a series of Activation-Likelihood Estimate (ALE) meta-analyses on published fMRI studies of itch. These analyses are empirically driven, and use brain activation coordinates across the published literature to identify similarities (i.e., clusters) of brain activation that are consistently associated with a particular process or experimental manipulation. A previous coordinates-based meta-analysis examined acute itch in healthy volunteers across 14 studies13, and identified consistent foci across regions of the Secondary Somatosensory Cortex, Bilateral Anterior Insula, Supplementary Motor Area, Inferior Parietal Cortex, and Inferior Frontal Gyrus. Further to this, a previous meta-analysis examined the similarities and differences in itch and pain, within studies that report comparisons for both itch and pain14. Here we build upon these initial studies, to offer an analysis of the overarching neural mechanisms associated with itch across the published literature, and report how this brain activation may differ for healthy participants and clinical groups. Furthermore, we highlight the promise of transdiagnostic psychological interventions such as cognitive behaviour therapy (CBT), mindfulness, and compassion-based approaches, that have shown much promise in reducing distress associated with chronic itch15–18. Indeed, to train individuals who experience chronic itch in strategies for regulating itch-related distress, may help to improve their quality of life and reduce potential concurrent presentations of depression, stress, anxiety, and disgust15–18, indirectly improving the ‘itch/scratch cycle’.

Results

Overview

From the twenty studies that passed the inclusion criteria19–38, we included all voxels that the authors explicitly interpreted as reflecting significant itch-related activity, such as a whole-brain contrast of itch and a neutral condition. If studies reported original voxels in Talairach space, these were transformed into MNI space using the tal2mni algorithm implemented within the ALE software. Our first ALE-analysis identified shared neural activation and deactivation associated with itch, pooled across healthy participants and clinical groups (Fig. 1, Tables 1 and 2). Our second ALE analysis explored how neural markers of itch may differ across healthy participants and clinical groups (Fig. 2, Tables 3 and 4). We also report details of each study’s stimuli and experimental design, as well as the populations sampled (Table 5). As shown below, we compared the coordinates of our ALE-activation with published data, reviews and meta-analyses, to provide convergent evidence for the labels applied automatically from the ALE software.Figure 1 Shared Brain Regions for Itch across Published fMRI Studies. This figure demonstrates significant shared activation and deactivation associated with itch. Figure legend indicates ALE activation map (orange) and ALE deactivation map (green). Colour bar indicates the Activation-Likelihood Estimate (ALE) test-statistic, which is the degree of convergence of activation across multiple studies within a given voxel. (a) These clusters show significant activation across Bilateral Thalamus and Basal Ganglia circuits, including Putamen. (b) These clusters show significant deactivations in Medial Frontal Gyrus and Paracentral Lobule. (c) This cluster shows significant activation across Basal Ganglia/Thalamus extending through the midbrain. (d) These clusters show activation across Bilateral Insula and Inferior Frontal Gyri, as well as Left Thalamus. These ALE maps were corrected at a cluster-level threshold of FWE, p < .05, with a voxel-level forming threshold at p < .001, uncorrected.

Table 1 Significant brain activations associated with itch across 20 fMRI studies.

Cluster #	x	y	z	ALE	P	Z	Label (Nearest Gray Matter within 5 mm)	N. contributing experiments	
1 (7840 mm3)	− 6	− 18	10	0.04	3.53E−09	5.80	Left Thalamus: Medial Dorsal Nucleus	10/20 (50%)	
− 10	− 10	6	0.04	6.07E−09	5.70	Left Thalamus: Ventral Lateral Nucleus	
− 6	− 8	6	0.04	8.03E−09	5.65	Left Thalamus: Medial Dorsal Nucleus	
− 20	− 16	0	0.03	3.90E−06	4.47	Left Thalamus	
− 6	− 22	− 10	0.03	4.82E−06	4.43	Left Brainstem: Red Nucleus	
− 20	− 10	0	0.02	1.27E−05	4.21	Left Lentiform Nucleus: Medial Globus Pallidus	
2 (5472 mm3)	− 36	18	− 8	0.03	1.40E−08	5.55	Left Insula (Brodmann area 13)	11/20 (55%)	
− 34	14	− 2	0.03	3.57E−08	5.34	Left Claustrum	
− 48	20	− 12	0.03	2.82E−07	5.00	Left Inferior Frontal Gyrus (Brodmann area 47)	
− 38	− 2	0	0.02	1.03E−05	4.26	Left Claustrum	
− 28	24	4	0.02	9.97E−05	3.72	Left Claustrum	
− 44	10	− 4	0.02	1.18E−04	3.68	Left Insula (Brodmann area 13)	
3 (5384 mm3)	36	24	2	0.03	3.22E−07	4.98	Right Insula (Brodmann area 13)	13/20 (65%)	
26	4	4	0.03	4.02E−07	4.93	Right Lentiform Nucleus: Putamen	
40	10	− 4	0.03	1.98E−06	4.61	Right Claustrum	
44	0	10	0.02	8.14E−05	3.77	Right Insula (Brodmann area 13)	
36	20	− 10	0.02	8.73E−05	3.75	Right Insula (Brodmann area 47)	
54	− 2	6	0.02	4.15E−04	3.34	Right Precentral Gyrus (Brodmann area 6)	
4 (1240 mm3)	12	− 4	0	0.02	1.44E−05	4.18	Right Thalamus	7/20 (35%)	
16	− 2	8	0.02	1.16E−04	3.68	Right Thalamus: Ventral Anterior Nucleus	
5 (1072 mm3)	− 38	− 14	− 4	0.03	2.43E−06	4.57	Left Claustrum	4/20 (20%)	
− 38	− 20	0	0.02	1.34E−05	4.20	Left Claustrum	
− 36	− 20	10	0.02	9.37E−04	3.20	Left Claustrum	
Note. The XYZ column indicates coordinates referenced to MNI-space, Activation-Likelihood Estimate (ALE) column indicates the ALE test-statistic (which is the degree of convergence of activation across multiple studies within a given voxel), P and Z columns indicate ALE map statistics, Label column indicates automatic labelling from the ALE software, and N. Contributing Experiments column describes the number and percentage of total papers which contributed foci to each cluster. 40 experimental contrasts with a total n = 728 were included in this analysis to reveal 1008 foci.

Table 2 Significant brain deactivations associated with itch across 6 fMRI studies.

Cluster #	x	y	z	ALE	P	Z	Label (Nearest Gray Matter within 5 mm)	N. contributing experiments	
1 (816 mm3)	4	− 20	50	0.01	4.16E−06	4.40	Paracentral Lobule (Brodmann area 31)	2/6 (33%)	
12	− 26	46	0.01	6.59E−05	3.82	Paracentral Lobule (Brodmann area 31)		
2 (656 mm3)	4	60	12	0.02	1.20E−08	5.58	Medial Frontal Gyrus (Brodmann area 9)	1/6 (17%)	
Note. The XYZ column indicates coordinates referenced to MNI-space, Activation-Likelihood Estimate (ALE) column indicates the ALE test-statistic (which is the degree of convergence of activation across multiple studies within a given voxel), P and Z columns indicate ALE map statistics, Label column indicates automatic labelling from the ALE software, and N. Contributing Experiments column describes the number and percentage of total papers which contributed foci to each cluster.

Figure 2 Brain Regions for Itch as a Function of Participant Groups. This figure demonstrates significant brain activation associated with itch across healthy participants and clinical groups. Figure legend indicates ALE map for healthy participants (blue) and ALE map for clinical groups (gold). Colour bar indicates the Activation-Likelihood Estimate (ALE) test-statistic, which is the degree of convergence of activation across multiple studies within a given voxel. Across both axial (a) and coronal (b) images, significant activation across Thalamus and Basal Ganglia circuits were observed for healthy participants, as opposed to activation of the Paracentral Lobule for clinical groups (a, b). These ALE maps were corrected at a cluster-level threshold of FWE, p < .05, with a voxel-level forming threshold at p < .001, uncorrected.

Table 3 Significant ALE activation associated with itch across healthy participants (17 total studies).

Cluster #	x	y	z	ALE	P	Z	Label (Nearest Gray Matter within 5 mm)	N. contributing experiments	
1 (6208 mm3)	− 10	− 10	6	0.04	1.05E−09	5.99	Left Thalamus: Ventral Lateral Nucleus	9/17 (53%)	
− 6	− 8	6	0.04	1.56E−09	5.93	Left Thalamus: Medial Dorsal Nucleus	
− 18	− 18	− 2	0.02	7.08E−06	4.34	Left Thalamus	
− 20	− 8	0	0.02	1.24E−04	3.66	Left Lentiform Nucleus: Lateral Globus Pallidus	
2 (5160 mm3)	− 36	18	− 8	0.03	5.35E−09	5.72	Left Insula (Brodmann area 13)	10/17 (59%)	
− 48	20	− 12	0.03	2.68E−07	5.01	Left Inferior Frontal Gyrus (Brodmann area 47)	
− 42	− 2	2	0.02	1.52E−05	4.17	Left Insula (Brodmann area 13)	
− 44	12	− 2	0.02	1.18E−04	3.68	Left Insula (Brodmann area 13)	
− 28	24	4	0.02	1.88E−04	3.56	Left Claustrum	
− 46	12	2	0.02	1.92E−04	3.55	Left Insula (Brodmann area 13)	
3 (3672 mm3)	36	24	2	0.03	6.01E−08	5.29	Right Insula (Brodmann area 13)	8/17 (47%)	
38	12	− 4	0.03	6.56E−07	4.84	Right Claustrum	
36	20	− 10	0.02	2.73E−05	4.04	Right Insula (Brodmann area 47)	
4 (1920 mm3)	12	− 2	0	0.02	4.11E−06	4.46	Right Lentiform Nucleus: Medial Globus Pallidus	7/17 (41%)	
16	− 2	8	0.02	3.75E−05	3.96	Right Thalamus: Ventral Anterior Nucleus	
14	− 16	8	0.02	2.86E−04	3.44	Right Thalamus: Medial Dorsal Nucleus	
5 (1224 mm3)	26	4	4	0.03	2.80E−07	5.00	Right Lentiform Nucleus: Putamen	4/17 (24%)	
Note. The XYZ column indicates coordinates referenced to MNI-space, Activation-Likelihood Estimate (ALE) column indicates the ALE test-statistic (which is the degree of convergence of activation across multiple studies within a given voxel), P and Z columns indicate ALE map statistics, Label column indicates automatic labelling from the ALE software, and N. Contributing Experiments column describes the number and percentage of total papers which contributed foci to each cluster.

Table 4 Significant ALE activation associated with itch across clinical patient groups (6 total studies).

Cluster #	x	y	z	ALE	P	Z	Label (Nearest Gray Matter within 5 mm)	N. contributing experiments	
1 (976 mm3)	0	− 8	50	0.02	4.15E−08	5.36	Left Paracentral Lobule (Brodmann area 31)	3/6 (50%)	
Note. Clinical patient groups include individuals who report chronic itch (Mochizuki et al., 2015), atopic dermatitis (Ishuji et al., 2009), and itch associated with end-stage renal disease (Papoui et al., 2014). The XYZ column indicates coordinates referenced to MNI-space, Activation-Likelihood Estimate (ALE) column indicates the ALE test-statistic (which is the degree of convergence of activation across multiple studies within a given voxel), P and Z columns indicate ALE map statistics, Label column indicates automatic labelling from the ALE software, and N. Contributing Experiments column describes the number and percentage of total papers which contributed foci to each cluster.

Table 5 Paradigms, stimuli and sample characteristics across studies included in our meta-analysis.

Authors	Paradigm/stimulus	Sample characteristics	Contrasts extracted	
Herde et al.19	Histamine and Codeine applied through microdialysis fiber (first experiment). Heat pain was next provoked in the right forearm (second experiment)	10 Healthy participants (itch experiment) (8 female, mean age 23 years) and 8 Healthy participants (pain experiment)	Scratch vs Control

Itch vs Control

Itch Rating

Pain Rating

	
Holle et al.20	Short video clips used to elicit contagious itch and scratching versus control video	18 Healthy participants 9female,meanage21years	Scratch vs Control	
Ishiuji et al.21	Itch evoked by iontophoresis of histamine into lesional skin of the forearm	7 Healthy participants (4 female, mean age 35 years), 8 Atopic Dermatitis Patients (3 female, mean age 33 years)	Histamine induced activation (atopic dermatitis group)

Histamine induced activation (healthy participants)

Histamine induced activation (atopy minus healthy controls)

	
Kim et al.22	Stress induced itching elicited from presentation of visual stimuli depicting fearful or stressful (versus neutral) situations. Antihistamine was also applied to examine if it reduced stress-related itching	14 Patients with scratching lesions (either prurigo nodularis or lichen simplex chronicus) (5 female, mean age 48 years)	Stress induced brain activation to itching

Histamine—saline with one minute temporal analysis

Reduction in brain activity after sedating anti histamine, decrease

Reduction in brain activity after non-sedating anti histamine, decrease

	
Kleyn et al.23	Histamine-induced itch elicited from skin prick	16 Healthy participants (0 female, mean age 24 years)	Histamine—saline	
Leknes et al.24	Itch induced via skin prick from allergen and/or histamine solutions	15 Healthy participants 7female,meanageestimatedas34and44yearsofage,dependingonthesubjectgroup	Allergen induced itch

Histamine induced itch

	
Mochizuki et al.25	Itch and pain elicited through histamine stimuli and cold/cold-pain stimulus	14 Healthy participants (0 female, mean age 26 years)	Histamine condition	
Mochizuki et al.26	Electrically-evoked itch generated from an electrical stimulator, applied to the wrist	10 Healthy participants (0 female, mean age 32 years)	Electrically evoked itch	
Mochizuki et al.27	Combination of itch imagery, pain imagery, and control conditions for pain and imagery	18 Healthy participants (mean age 23 years)	Itch imagery > Control	
Mochizuki et al.28	This experiment incorporated four conditions; baseline scan, scratching (alone), itch (alone), and scratching an itch	10 Healthy participants (4 female, mean age 37 years) and 10 Chronic Itch patients (3 female, mean age 31 years)	Scratch itch, Chronic Itch Patients

Scratch itch, Healthy Control

Scratch itch, patients > controls

Itch alone, control > patients

Itch alone, Chronic Itch Patients

Itch alone, Healthy Controls

Itch alone, patients > controls

Itch alone, control > patients

	
Napadow et al.29	Nocebo itch versus saline control to examine imagined itch	14 Atopic Dermatitis Patients (8 female, mean age 25 years)	Nocebo-induced itch > open saline	
Papoiu et al.30	Neural responses measured toward cowhage versus histamine induced itch	15 Healthy participants (8 female, mean age 31 years)	Cowhage itch > baseline

Cowhage itch > histamine response

Cowhage itch & histamine response

	
Papoiu et al.31	Itch generated by the subjects themselves or as performed by an investigator. Brain responses were correlated with ‘pleasurability’ and ‘relief’ of itch	14 Healthy participants (8 female, mean age 30)	Brain areas correlated with pleasurability of itch scratch

Brain areas correlated with itch relief during scratching

	
Papoiu et al.32	Histamine itch inducted from iontophoresis into the forearm, and cowhage was rubbed on another area of the arm	13 End-Stage Renal Disease (ESRD) patients with chronic itch (5 female, mean age 51 years)	Higher cerebral perfusion in ESRD than healthy participants

Cowhage itch in ESRD

Histamine evoked itch reaction in ESRD

	
Schut et al.33	Participants were presented with two videos, one itch inducing and one not itch inducing	11 Atopic Dermatitis Patients (6 female, mean age 33 years)	Contagious Itch in AD patient

Correlation between induced itch and the activation of brain regions during CI

	
Stumpf et al.34	Itch stimulation created from injection of histamine into the forearm, followed by a stroop task (counterbalanced across runs)	33 Healthy participants 17female,meanage24yearsforfemales,and27yearsformales	Sex differences in itch (females > males)

Sex differences in itch (males > females)

Sex-specific activation under Stroop (females > males)

Sex-specific activation under Stroop (males > females)

Sex-specific activation during forearm stimulation (females > males)

Sex-specific activation during forearm stimulation (males > females)

	
Stumpf et al.35	Data were gathered from a baseline, itch, and stroop condition. Itch was elicited from intradermal injection into the left forearm and left lower leg	33 Healthy participants (mean age 26 years). No information on gender/sex of the participants	Contrast of Itch and Stroop	
Valet et al.36	Histamine-induced itch with short-term alternating temperature modulation	12 Healthy participants (0 female, mean age 28 years)	Cerebral processing of histamine itch. Increase

Histamine > Saline, increase

Cerebral processing of histamine itch. Decrease

Histamine > Saline, decrease

	
Van der Sand et al.37	Nocebo-induced itch examined with thermal stimulation	38 Healthy participants (26 female, mean age 26 years)	Itch and nocebo > itch only, increase	
Yosipovitch et al.38	Scratch versus no scratch stimuli. Participants were scratched by the experimenter with a cytology brush	13 Healthy participants (6 female, mean age 28 years)	Scratch activation (increase)

Scratch de-activation (decrease)

Itch and nocebo > itch only, decrease

	

Activation and deactivation map

Our first ALE-analysis explored significant neural activation and deactivation associated with itch, pooled across healthy participants and clinical groups. Overall, this analysis identified 5 clusters for shared neural activation, and 2 clusters for shared neural deactivation. For the activation map, 40 experimental contrasts were included, that comprised 1008 foci from a total of n = 728 subjects. For the decrease map, 6 experimental contrasts were included that comprised 56 foci from a total of 131 subjects. For shared neural activation (as shown in Table 1 and Fig. 1), clusters identified from this ALE-analysis include nuclei of the Left Thalamus (cluster 1); Left Insula, Claustrum, Left Inferior Frontal Gyrus, and Left Insula (cluster 2); Right Insula, Right Putamen, Right Claustrum, and Right Precentral Gyrus (cluster 3); Right Thalamus (cluster 4) and Left Claustrum (cluster 5). For shared neural deactivation (as shown in Fig. 1 and Table 2), clusters identified from the ALE-analysis include Paracentral Lobule (cluster 1) and Medial Frontal Gyrus (cluster 2).

Increase map: cluster 1

The first cluster identified in the ‘activation’ map had a volume of 7840 mm3, spanning from (− 24, − 32, − 18) to (0, 0, 14) centered at (− 10, − 14.9, 2) with 6 peaks with a max value of 0.0369 ALE, 3.5330288E-9 P, 5.79 Z at (− 6, − 18, 10). Activation from these coordinates have been attributed to the Medial Dorsal Nucleus39 and Ventral Lateral Nucleus40 of the Left Thalamus41, as well as the Red Nucleus of the Left Brainstem/Midbrain42,43, as well as the Left Lentiform Nucleus44. Ten studies contributed foci to this cluster25–34. Note that one study34 included 2 foci for an itch rating, and 2 foci for a pain rating.

Increase map: cluster 2

The second cluster identified from the ‘activation’ map had a volume of 5472 mm3 from (− 52, − 4, − 16) to (− 26, 26, 8) centered at (− 37.9, 13.8, − 4.8) with 6 peaks with a max value of 0.035 ALE, 1.4005524E−8 P, 5.55 Z at (− 36, 18, − 8). Activation from these coordinates have been attributed to the Left Claustrum45,46, Left Inferior Frontal Gyrus47,48 and Left Insula49,50. Twelve studies contributed foci to this cluster25–30,32,34–38.

Increase map: cluster 3

The third cluster identified had a 5384 mm3 from (22, − 6, − 14) to (56, 26, 14) centered at (37, 9.8, 1.6) with 6 peaks with a max value of 0.0303 ALE, 3.218045E−7 P, 4.98 Z at (36, 24, 2). Eleven studies contributed foci to this cluster (25–27, 30–35, 37, 39). Note that one study34 included 2 foci for an itch rating, and 2 foci for a pain rating. Activation from these coordinates have been attributed to the Right Claustrum45,46 and Right Insula51, as well as the Right Lentiform Nucleus and Putamen, as situated within the Basal Ganglia52,53, as well as the Right Precentral Gyrus54,55.

Increase map: cluster 4 and 5

The fourth cluster had a volume of 1240 mm3 from (8, − 12, − 4) to (18, 2, 12) centered at (12.9, − 3.9, 2.4) with 2 peaks with a max value of 0.0243 ALE, 1.4436547E−5 P, 4.18 Z at (12, − 4, 0). Seven studies contributed foci to this cluster25,27–31,34. Note that one study34 included 2 foci for an itch rating, and 2 foci for a pain rating. Activation from these coordinates have been attributed to the Right Thalamus56 as well as the Left Claustrum57. The fifth cluster had a volume of 1072 mm3 from (− 40, − 26, − 8) to (− 34, − 8, 10) centered at (− 37.2, − 16.5, − 1.9) with 3 peaks with a max value of 0.0272 ALE, 2.4281858E−6 P, 4.57 Z at (− 38, − 14, − 4). Four studies contributed foci to this cluster27,30,32,39.

Decrease map: cluster 1 and 2

For the decrease map, cluster 1 included 816 mm3 from (− 2, − 28, 44) to (14, − 16, 54) centered at (4.7, − 22.1, 49.1) with 2 peaks with a max value of 0.0126 ALE, 4.1608578E−6 P, 4.46 Z at (4, − 20, 50). Two studies contributed foci to this cluster29,49. Cluster 2 included 656 mm3 from (− 2, 56, 8) to (8, 64, 16) centered at (3.1, 59.9, 11.7) with 1 peaks with a max value of 0.0181 ALE, 1.1981463E−8 P, 5.58 Z at (4, 60, 12). One study contributed foci to this cluster29. Activation from these coordinates have been attributed to the Paracentral Lobule58–60 as well as the Medial Frontal Gyrus61.

Healthy participants and clinical groups map

This ALE map explored neural activation associated with itch for healthy participants and clinical groups (Fig. 2, Tables 3 and 4). For the healthy participants map, 34 experimental contrasts were included, that comprised 748 foci from a total of n = 714 subjects. For the clinical groups map, 12 experimental contrasts were included that comprised 316 foci from a total of 145 subjects. Given that the shared neural activation for healthy participants comprise approximately the same clusters as identified for the above ‘activation’ map (i.e., Fig. 1, Table 1), this was not compared to previously published coordinates, yet details for this analysis are provided on the OSF (see “Methods” for a link to the repository). In contrast, the shared neural activation with clinical groups included 1 cluster of 976 mm3 from (− 6, − 16, 46) to (4, − 4, 56) centered at (− 0.8, − 9.4, 51.3) with 1 peaks with a max value of 0.0218 ALE, 4.1508642E−8 P, 5.36 Z at (0, − 8, 50). Three studies contributed foci to this cluster27,32,38. Activation from these coordinates have been attributed to the Left Paracentral Lobule57–59 as part of the Medial Frontal Gyrus.

Table of stimuli and paradigms

Table 5 outlines the stimuli and paradigms used within each fMRI experiment, as well as demographic information for the populations that were studied (i.e., healthy participants or clinical groups).

Discussion

We used a coordinates-based approach to synthesize pre-existing fMRI studies of itch, in order to identify replicable brain regions consistently reported to be associated with itch. We found evidence for a core “itch network” that comprised the Basal Ganglia/Thalamus, Bilateral Insula, and Claustrum, as well as the Inferior Frontal Gyrus and Precentral Gyrus. These brain regions are consistent with studies that have identified how histamine-induced itch can modulate regions of the Basal Ganglia/Thalamus, such as the Caudate Nucleus and Putamen62,63, as well as research that has shown how cowhage-induced itch can activate the Insula, Claustrum and Basal Ganglia/Thalamus64. The Thalamus and Claustrum have been attributed a key role in attention and multisensory integration65,66, and the Insula has been implicated in tasks that require attentional control and response inhibition48,49, particulary in contexts of emotional salience67,68.

In addition to our activation map, we also examined neural deactivation associated with itch. Although these results showed fewer foci, we identified significant neural deactivation in both the Paracentral Lobule and Medial Frontal Gyrus. Of note, the Paracentral Lobule has previously been associated with cognitive/executive control59 and response inhibition60, whereas the Medial Frontal Gyrus has previously been associated with social cognition and mentalising61,69. Thus, that regions associated with cognitive control and task demands (i.e., Paracentral Lobule)70–72 are shown to deactivate during itch, might suggest a putative marker for how the experience of itch may dysregulate executive control. However, given only three studies contributed foci to this ALE map, this finding should be interpreted with caution. Given the multifunctional role of these two brain regions, we acknowledge that alternative explanations unrelated to cognitive control, response inhibition or mentalising are possible. Future research is needed to examine these processes in relation to itch with carefully designed empirical experiments.

Unique neural activation for health controls and clinical groups

A further focus of this paper was to explore how neural activation during itch may be unique across healthy participants and clinical groups (i.e., individuals with atopic dermatitis). When examining neural markers of itch for health controls, we identified five clusters of activation (Fig. 2), across similar brain regions identified in the activation map reported above (Fig. 1). When examining neural markers of itch for the clinical groups, however, we identified significant recruitment of the Left Paracentral Lobule (Fig. 2), a brain region previously associated with cognitive control and response inhibition58–60. To examine the influence of cognitive control during the experience of itch in future experimental studies will provide precise evidence to inform how the urge to itch may be interrupted via executive function73.

Limitations and future directions

Within this paper we pooled across various clinical groups who report chronic itch due to the small number of studies with clinical groups (Table 5). Although this approach provided further insights as to the neurobiology of itch in clinical groups, it is likely that neural/immune mechanisms for itch could vary across specific clinical conditions (e.g., in the case of atopic dermatitis and psoriasis)1. Furthermore, given few studies have examined itch in clinical groups with fMRI, we did not have the statistical power to compare how neural activation for itch may differ between healthy participants versus clinical groups, or between clinical groups versus healthy participants. Indeed, our ALE activation of itch incorporated foci from only three studies, albeit with two distinct clusters. While this finding should be interpreted with relative caution given the small sample-size, future studies can help inform our understanding of this initial evidence that suggests the Left Paracentral Lobule and the Medial Frontal Gyrus as associated with itch for those who report chronic itch. It is also worth noting that the extracted contrasts used in the analysis for this paper are quite diverse. As an example, while most included studies focus on physically induced itch, there was also a study that used visually induced itch. We also included a contrast that examined an effect of sex (i.e., neural markers of itch for males versus females), as well as a correlation between pleasurability ratings and neural markers of itch. Given these diverse (but perhaps more inclusive) inputs in our analysis, it is unsurprising that certain brain regions previously associated with itch found in prior meta-analyses (i.e., Primary Somatosensory Cortex)11,13 were not identified.

It is important for future research to continue to examine the neural correlates of itch within clinical groups, to provide further support for how to best understand and treat these conditions. Indeed, there is a substantial burden of disease associated with living with chronic itch, evident through the downstream impact of these conditions on mental health15,16.

Experimental extensions

The “itch network” identified in this research has potential implications for ways to treat and mitigate itch in clinical settings. The identification of this interconnected network implies that a treatment targeting any node in this network has the potential for ripple on effects so to speak, to influence the entire system. To draw on parallel research within the area of pain, the historical “Gate Control Theory of Pain”—now known as the “Neuromatrix Model of Pain”74,75—revolutionised how pain was conceptualized and treated. This model was the first to recognize the interconnected role of areas such as the prefrontal cortex and amygdala (and others) in processing pain, which essentially broadened the traditional points of biomedical intervention to recognize the capacity for psychological interventions targeting such cognitive and emotion centres to harness modulatory processes. Now, the neuroscience of pain relief is included as a treatment rational in educational interventions76, cognitive-behavioural therapy77, and mindfulness-based cognitive therapy78, and emerging research is showing how changes in brain function during such treatment are driven by change in psychological processes (e.g.,79,80).

Linking this line of research back to itch, convergent evidence from clinical psychology has shown how training in mindfulness and compassion-based approaches can reduce the presentation of depression and/or anxiety associated with chronic itch81–83. Indeed, several randomised control trials (RCTs) have previously demonstrated the efficacy of cognitive behavioural therapy (CBT) for improving mental distress associated with atopic dermatitis81–84, and mindfulness and compassion-based approaches have been shown to improve emotional regulation, stress reduction and improved cognitive control85–88.

Possibly, these treatments are efficacious as they are engendering functional shifts within the neural “itch network” identified in this current study; it would be fascinating to explore such a possibility with experimental fMRI, particularly given the need to develop novel therapies for itch12, through the recognition of psychological factors implicated in the exacerbation or treatment of chronic itch. The findings from such future research could be harnessed in a similar way as the research on the neuroscience of pain and its relief has been used. That is, to develop targeted treatments with a clear rationale to engender positive outcome expectancies and “buy in” that psychological, non-pharmacological treatments are effective for itch, what has long been considered a purely “biomedical problem”.

Conclusions

Conditions such as atopic dermatitis comprise a large burden of disease89–91, with downstream consequences on mental health89,91,92. In this article, we explored the shared, consistent brain regions identified across the published literature for itch, and explored how these regions may differ for healthy participants and chronic itch populations. We provide evidence for a core “itch network” identified across the published literature to date, discuss the importance of executive control in inhibiting itch, and offer how training in mindfulness and/or compassion-based approaches may improve emotional regulation and executive control for chronic itch groups. We look forward to future research in compassion or mindfulness-based approaches to explore how these techniques might help individuals “put out the fire” of chronic itch.

Methods

The University of Queensland Low & Negligible Risk Ethics Sub-Committee approved the experimental protocol, and this project complies with the provisions contained in the National Statement of Ethical Conduct in Human Research and the regulations governing experimentation on humans.

Literature search and exclusion criteria

The PUBMED database was searched using the keywords ‘fMRI’ AND ‘itch’. The literature search was conducted in July 2020. Identification of studies occurred as follows:Studies that mentioned ‘fMRI’ and ‘itch’ within the title, abstract and/or keywords were identified, to collect experimental work which either manipulated or measured the neural markers of itch. This search identified 216 published, peer-reviewed papers. After removal of 7 duplicate articles and removing 1 record for other reasons (this study did not report whole brain results for analysis and was written in Japanese), 208 studies remained for screening.

208 studies were screened, and 179 studies were excluded from further analysis as they were not relevant to the present study. This left 29 studies for retrieval.

We sought to retrieve 29 studies that were relevant to the present paper. From this number, we did not retrieve 5 studies as these employed other imaging techniques that did not report relevant whole-brain markers (i.e., Diffusion Tensor Imaging, Pharmacological Methods). This left 24 studies to assess for eligibility.

We assessed 24 studies for eligibility, and excluded 4 studies that did not report relevant whole-brain analyses.

This left a total of 20 studies that were included in the present review.

Activation Likelihood Estimation (ALE) overview

In order to identify regions of consistent brain activation across studies, we performed a series of ALE analyses using the GingerALE software93 (Version 3.0.2). Practically, ALE analyses report 3D coordinates of published brain data within a text file, which also lists subject size and the reference space the data were originally reported in (i.e., MNI or Talairach). An advantage of this current ALE version (3.0.2) over older versions of the algorithm is the use of an ALE method which incorporates random effects93.

An ALE analysis with GingerALE entails three steps. First, a 3D image for each group of foci are created using a mask, foci from the text file, and a Gaussian blur with a Full-Width Half-Maximum (FWHM) smoothing generated from the sample-size. These images are referred to as Modelled Activation (MA) maps which are created for each foci’s Gaussian profile. The ALE image is a union of each MA map. Second, GingerALE calculates the null distribution of the ALE test-statistic, which represents the degree of convergence of brain activation within a voxel across all included experiments94. Combining the probabilities of finding each value in a MA map creates a table of p-values. The ALE image is combined with a p-value table to create a 3D p-value image. Third, a significance threshold can then be set for the p-value ALE map (i.e., uncorrected, false-discovery rate, family-wise error, FWE) (Supplementary Information).

Following recommendations from simulated data95, we used a cluster-level threshold of FWE, p < 0.05, with a voxel-level forming threshold at p < 0.001, uncorrected, with 5000 permutations. A cluster-based threshold indicates significant clusters of voxels where a test-statistic is above a pre-specified threshold96. Statistical tests are used to control the estimated rate of false positives of each cluster, that is, the probability of violating family-wise error within the cluster96. For our data, thresholded ALE maps were overlayed on a Colin27 T1 structural scan (courtesy of Simon Eickhoff, http://www.brainmap.org/ale/) using Mango (http://ric.uthscsa.edu/mango/). Each ALE analysis provides a table of cluster information with corresponding anatomical labels (nearest grey matter within 5 mm) which we discuss in this manuscript.

Ethical standards

This research was approved by The University of Queensland Health and Behavioural Science Low & Negligible Risk Ethics subcommittee.

Informed consent

This is a meta-analysis with no primary data collection. Individual studies included in this meta-analysis received informed voluntary consent for participation.

Supplementary Information

Supplementary Information.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-69973-5.

Author contributions

JJK and MAD wrote the main manuscript text and JJK conducted the analyses and prepared the figures and tables. Both authors reviewed the manuscript and have given approval for publication.

Data availability

Data that support this manuscript are available on the OSF: https://osf.io/zwr9v/?view_only=9d28575eb3ca4ee6af823665d8cb8771).

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Dainichi T Kitoh A Otsuka A Nakajima S Nomura T Kaplan DH Kabashima K The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis Nat. Immunol. 2018 19 563 10.1038/s41590-018-0256-2
Dainichi, T. et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat. Immunol. 19, 563. 10.1038/s41590-018-0256-2 (2018).10.1038/s41590-018-0256-2
2. Dong X Dong X Review peripheral and central mechanisms of itch Neuron 2018 98 3 482 494 10.1016/j.neuron.2018.03.023 29723501
Dong, X. & Dong, X. Review peripheral and central mechanisms of itch. Neuron 98(3), 482–494. 10.1016/j.neuron.2018.03.023 (2018).29723501 10.1016/j.neuron.2018.03.023
3. Misery L Brenaut E Le Garrec R Abasq C Genestet S Marcorelles P Zagnoli F Neuropathic pruritus Nat. Rev. Neurol. 2014 10 7 408 416 10.1038/nrneurol.2014.99 24912513
Misery, L. et al. Neuropathic pruritus. Nat. Rev. Neurol. 10(7), 408–416. 10.1038/nrneurol.2014.99 (2014).24912513 10.1038/nrneurol.2014.99
4. Sidler D Wu P Herro R Claus M Wolf D Kawakami Y Kawakami T Burkly L Croft M atopic dermatitis and psoriasis Nat. Commun. 2017 2017 1 11 10.1038/ncomms15395
Sidler, D. et al. atopic dermatitis and psoriasis. Nat. Commun. 2017, 1–11. 10.1038/ncomms15395 (2017).10.1038/ncomms15395
5. Weidinger S Beck LA Bieber T Kabashima K Irvine AD Atopic dermatitis Nat. Rev. Dis. Prim. 2018 10.1038/s41572-018-0001-z 29930242
Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K. & Irvine, A. D. Atopic dermatitis. Nat. Rev. Dis. Prim.10.1038/s41572-018-0001-z (2018).29930242 10.1038/s41572-018-0001-z
6. Jeschke MG van Baar ME Choudhry MA Chung KK Gibran NS Logsetty S Burn injury Nat. Rev. Dis. Prim. 2020 6 1 859 10.1038/s41572-020-0145-5
Jeschke, M. G. et al. Burn injury. Nat. Rev. Dis. Prim. 6(1), 859. 10.1038/s41572-020-0145-5 (2020).10.1038/s41572-020-0145-5
7. Richardson C Glenn S Nurmikko T Horgan M Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease Clin. J. Pain 2006 22 4 353 358 10.1097/01.ajp.0000177793.01415.bd 16691088
Richardson, C., Glenn, S., Nurmikko, T. & Horgan, M. Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease. Clin. J. Pain 22(4), 353–358. 10.1097/01.ajp.0000177793.01415.bd (2006).16691088 10.1097/01.ajp.0000177793.01415.bd
8. Samineni VK Grajales-Reyes JG Sundaram SS Yoo JJ Gereau RW Cell type-specific modulation of sensory and affective components of itch in the periaqueductal gray Nat. Commun. 2019 10 1 1 15 10.1038/s41467-019-12316-0 30602773
Samineni, V. K., Grajales-Reyes, J. G., Sundaram, S. S., Yoo, J. J. & Gereau, R. W. Cell type-specific modulation of sensory and affective components of itch in the periaqueductal gray. Nat. Commun. 10(1), 1–15. 10.1038/s41467-019-12316-0 (2019).30602773 10.1038/s41467-019-12316-0
9. Serhan N Basso L Sibilano R Petitfils C Meixiong J Bonnart C Reber LL Marichal T Starkl P Cenac N Dong X Tsai M Galli SJ Gaudenzio N House dust mites activate nociceptor–mast cell clusters to drive type 2 skin inflammation Nat. Immunol. 2019 20 11 1435 1443 10.1038/s41590-019-0493-z 31591569
Serhan, N. et al. House dust mites activate nociceptor–mast cell clusters to drive type 2 skin inflammation. Nat. Immunol. 20(11), 1435–1443. 10.1038/s41590-019-0493-z (2019).31591569 10.1038/s41590-019-0493-z
10. Solinski HJ Dranchak P Oliphant E Gu X Earnest TW Braisted J Inglese J Hoon MA Inhibition of natriuretic peptide receptor 1 reduces itch in mice Sci. Transl. Med. 2019 11 500 1 15 10.1126/scitranslmed.aav5464
Solinski, H. J. et al. Inhibition of natriuretic peptide receptor 1 reduces itch in mice. Sci. Transl. Med. 11(500), 1–15. 10.1126/scitranslmed.aav5464 (2019).10.1126/scitranslmed.aav5464
11. Ikoma A Steinhoff M Ständer S Yosipovitch G Schmelz M The neurobiology of itch Nat. Rev. Neurosci. 2006 7 535 547 10.1038/nrn1950 16791143
Ikoma, A., Steinhoff, M., Ständer, S., Yosipovitch, G. & Schmelz, M. The neurobiology of itch. Nat. Rev. Neurosci. 7, 535–547. 10.1038/nrn1950 (2006).16791143 10.1038/nrn1950
12. Mochizuki H Kakigi R Itch and brain J. Dermatol. 2015 42 8 761 767 10.1111/1346-8138.12956 26046307
Mochizuki, H. & Kakigi, R. Itch and brain. J. Dermatol. 42(8), 761–767. 10.1111/1346-8138.12956 (2015).26046307 10.1111/1346-8138.12956
13. Jones O Schindler I Holle H Transcranial magnetic stimulation over contralateral primary somatosensory cortex disrupts perception of itch intensity Exp. Dermatol. 2019 28 12 1380 1384 10.1111/exd.13803 30325544
Jones, O., Schindler, I. & Holle, H. Transcranial magnetic stimulation over contralateral primary somatosensory cortex disrupts perception of itch intensity. Exp. Dermatol. 28(12), 1380–1384. 10.1111/exd.13803 (2019).30325544 10.1111/exd.13803
14. Roberts CA Where is itch represented in the brain, and how does it differ from pain? An activation likelihood estimation meta-analysis of experimentally-induced itch J. Investig. Dermatol. 2019 139 10 2245 2248 10.1016/j.jid.2019.04.007 31054845
Roberts, C. A. et al. Where is itch represented in the brain, and how does it differ from pain? An activation likelihood estimation meta-analysis of experimentally-induced itch. J. Investig. Dermatol. 139(10), 2245–2248. 10.1016/j.jid.2019.04.007 (2019).31054845 10.1016/j.jid.2019.04.007
15. Harfenstellar J An open trial on the feasibility and efficacy of a mindfulness-based intervention with psychoeducational elements on atopic eczema and chronic itch Psych 2022 4 2 160 172 10.3390/psych4020014
Harfenstellar, J. An open trial on the feasibility and efficacy of a mindfulness-based intervention with psychoeducational elements on atopic eczema and chronic itch. Psych 4(2), 160–172. 10.3390/psych4020014 (2022).10.3390/psych4020014
16. Sherman KA Roper T Kilby CJ Enhancing self-compassion in individuals with visible skin conditions: Randomised pilot of the ‘My Changed Body’ self-compassion writing intervention Health Psychol. Behav. Med. 2019 7 1 62 77 10.1080/21642850.2019.1587298 34040839
Sherman, K. A., Roper, T. & Kilby, C. J. Enhancing self-compassion in individuals with visible skin conditions: Randomised pilot of the ‘My Changed Body’ self-compassion writing intervention. Health Psychol. Behav. Med. 7(1), 62–77. 10.1080/21642850.2019.1587298 (2019).34040839 10.1080/21642850.2019.1587298
17. Clarke EN Thompson AR Norman P Depression in people with skin conditions: The effects of disgust and self-compassion Br. J. Psychol. 2020 25 540 557 10.1111/bjhp.12421
Clarke, E. N., Thompson, A. R. & Norman, P. Depression in people with skin conditions: The effects of disgust and self-compassion. Br. J. Psychol. 25, 540–557. 10.1111/bjhp.12421 (2020).10.1111/bjhp.12421
18. Clarke EN Norman P Thompson AR How does self-compassion help people adjust to chronic skin conditions? A template analysis study Front. Med. 2022 9 456 10.3389/fmed.2022.974816
Clarke, E. N., Norman, P. & Thompson, A. R. How does self-compassion help people adjust to chronic skin conditions? A template analysis study. Front. Med. 9, 456. 10.3389/fmed.2022.974816 (2022).10.3389/fmed.2022.974816
19. Herde L Forster C Strupf M Handwerker HO Itch induced by a novel method leads to limbic deactivations a functional MRI study J. Neurophysiol. 2007 98 4 2347 2356 10.1152/jn.00475.2007 17715198
Herde, L., Forster, C., Strupf, M. & Handwerker, H. O. Itch induced by a novel method leads to limbic deactivations a functional MRI study. J. Neurophysiol. 98(4), 2347–2356. 10.1152/jn.00475.2007 (2007).17715198 10.1152/jn.00475.2007
20. Holle H Warne K Seth AK Critchley HD Ward J Neural basis of contagious itch and why some people are more prone to it Proc. Natl. Acad. Sci. U. S. A. 2012 109 48 19816 19821 10.1073/pnas.1216160109 23150550
Holle, H., Warne, K., Seth, A. K., Critchley, H. D. & Ward, J. Neural basis of contagious itch and why some people are more prone to it. Proc. Natl. Acad. Sci. U. S. A. 109(48), 19816–19821. 10.1073/pnas.1216160109 (2012).23150550 10.1073/pnas.1216160109
21. Ishiuji Y Coghill RC Patel TS Oshiro Y Kraft RA Yosipovitch G Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis Br. J. Dermatol. 2009 161 5 1072 1080 10.1111/j.1365-2133.2009.09308.x 19663870
Ishiuji, Y. et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br. J. Dermatol. 161(5), 1072–1080. 10.1111/j.1365-2133.2009.09308.x (2009).19663870 10.1111/j.1365-2133.2009.09308.x
22. Kim HJ Park JB Lee JH Kim I How stress triggers itch: A preliminary study of the mechanism of stress-induced pruritus using fMRI Int. J. Dermatol. 2015 55 434 10.1111/ijd.12864 26276021
Kim, H. J., Park, J. B., Lee, J. H. & Kim, I. How stress triggers itch: A preliminary study of the mechanism of stress-induced pruritus using fMRI. Int. J. Dermatol. 55, 434 (2015).26276021 10.1111/ijd.12864
23. Kleyn CE McKie S Ross A Elliott R Griffiths CEM A temporal analysis of the central neural processing of itch Br. J. Dermatol. 2012 166 5 994 1001 10.1111/j.1365-2133.2012.10849.x 22283926
Kleyn, C. E., McKie, S., Ross, A., Elliott, R. & Griffiths, C. E. M. A temporal analysis of the central neural processing of itch. Br. J. Dermatol. 166(5), 994–1001. 10.1111/j.1365-2133.2012.10849.x (2012).22283926 10.1111/j.1365-2133.2012.10849.x
24. Leknes SG Bantick S Willis CM Wilkinson JD Wise RG Tracey I Itch and motivation to scratch: An investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans J. Neurophysiol. 2007 97 1 415 422 10.1152/jn.00070.2006 16914620
Leknes, S. G. et al. Itch and motivation to scratch: An investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J. Neurophysiol. 97(1), 415–422. 10.1152/jn.00070.2006 (2007).16914620 10.1152/jn.00070.2006
25. Mochizuki H Sadato N Saito DN Toyoda H Tashiro M Okamura N Yanai K Neural correlates of perceptual difference between itching and pain: A human fMRI study NeuroImage 2007 36 3 706 717 10.1016/j.neuroimage.2007.04.003 17524669
Mochizuki, H. et al. Neural correlates of perceptual difference between itching and pain: A human fMRI study. NeuroImage 36(3), 706–717. 10.1016/j.neuroimage.2007.04.003 (2007).17524669 10.1016/j.neuroimage.2007.04.003
26. Mochizuki H Inui K Tanabe HC Akiyama LF Otsuru N Yamashiro K Sasaki A Nakata H Sadato N Kakigi R Time course of activity in itch-related brain regions: A combined MEG-fMRI study J. Neurophysiol. 2009 102 5 2657 2666 10.1152/jn.00460.2009 19710378
Mochizuki, H. et al. Time course of activity in itch-related brain regions: A combined MEG-fMRI study. J. Neurophysiol. 102(5), 2657–2666. 10.1152/jn.00460.2009 (2009).19710378 10.1152/jn.00460.2009
27. Mochizuki H Baumgärtner U Kamping S Ruttorf M Schad LR Flor H Kakigi R Treede R-D Cortico-subcortical activation patterns for itch and pain imagery Pain 2013 154 10 1989 1998 10.1016/j.pain.2013.06.007 23769719
Mochizuki, H. et al. Cortico-subcortical activation patterns for itch and pain imagery. Pain 154(10), 1989–1998. 10.1016/j.pain.2013.06.007 (2013).23769719 10.1016/j.pain.2013.06.007
28. Mochizuki H Papoiu ADP Nattkemper LA Lin AC Kraft RA Coghill RC Yosipovitch G Scratching induces overactivity in motor-related regions and reward system in chronic itch patients J. Investig. Dermatol. 2015 135 11 2814 2823 10.1038/jid.2015.223 26076316
Mochizuki, H. et al. Scratching induces overactivity in motor-related regions and reward system in chronic itch patients. J. Investig. Dermatol. 135(11), 2814–2823. 10.1038/jid.2015.223 (2015).26076316 10.1038/jid.2015.223
29. Napadow V Li A Loggia ML Kim J Mawla I Desbordes G Schalock PC Lerner EA Tran TN Ring J Rosen BR Kaptchuk TJ Pfab F The imagined itch: Brain circuitry supporting nocebo-induced itch in atopic dermatitis patients Allergy 2015 70 11 1485 1492 10.1111/all.12727 26280659
Napadow, V. et al. The imagined itch: Brain circuitry supporting nocebo-induced itch in atopic dermatitis patients. Allergy 70(11), 1485–1492. 10.1111/all.12727 (2015).26280659 10.1111/all.12727
30. Papoiu ADP Coghill RC Kraft RA Wang H Yosipovitch G A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch NeuroImage 2012 59 4 3611 3623 10.1016/j.neuroimage.2011.10.099 22100770
Papoiu, A. D. P., Coghill, R. C., Kraft, R. A., Wang, H. & Yosipovitch, G. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. NeuroImage 59(4), 3611–3623. 10.1016/j.neuroimage.2011.10.099 (2012).22100770 10.1016/j.neuroimage.2011.10.099
31. Papoiu ADP Brain’s reward circuits mediate itch relief a functional MRI study of active scratching PloS One 2013 8 12 e82389 10.1371/journal.pone.0082389 24324781
Papoiu, A. D. P. et al. Brain’s reward circuits mediate itch relief a functional MRI study of active scratching. PloS One 8(12), e82389. 10.1371/journal.pone.0082389 (2013).24324781 10.1371/journal.pone.0082389
32. Papoiu ADP Emerson NM Patel TS Kraft RA Valdes-Rodriguez R Nattkemper LA Coghill RC Yosipovitch G Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease J. Neurophysiol. 2014 112 7 1729 1738 10.1152/jn.00827.2013 24944217
Papoiu, A. D. P. et al. Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease. J. Neurophysiol. 112(7), 1729–1738. 10.1152/jn.00827.2013 (2014).24944217 10.1152/jn.00827.2013
33. Schut C Mochizuki H Grossman SK Lin AC Conklin CJ Mohamed FB Gieler U Kupfer J Yosipovitch G Brain processing of contagious itch in patients with atopic dermatitis Front. Psychol. 2017 8 1267 10.3389/fpsyg.2017.01267 28790959
Schut, C. et al. Brain processing of contagious itch in patients with atopic dermatitis. Front. Psychol. 8, 1267. 10.3389/fpsyg.2017.01267 (2017).28790959 10.3389/fpsyg.2017.01267
34. Stumpf A Burgmer M Schneider G Heuft G Schmelz M Phan NQ Ständer S Pfleiderer B Sex differences in itch perception and modulation by distraction—an FMRI pilot study in healthy volunteers PloS One 2013 8 11 e79123 10.1371/journal.pone.0079123 24260163
Stumpf, A. et al. Sex differences in itch perception and modulation by distraction—an FMRI pilot study in healthy volunteers. PloS One 8(11), e79123. 10.1371/journal.pone.0079123 (2013).24260163 10.1371/journal.pone.0079123
35. Stumpf A Pfleiderer B Schneider G Heuft G Schmelz M Phan NQ Ständer S Burgmer M Distraction from itch shows brainstem activation without reduction in experimental itch sensation Acta Dermato-Venereol. 2017 97 9 1074 1080 10.2340/00015555-2732
Stumpf, A. et al. Distraction from itch shows brainstem activation without reduction in experimental itch sensation. Acta Dermato-Venereol. 97(9), 1074–1080. 10.2340/00015555-2732 (2017).10.2340/00015555-2732
36. Valet M Pfab F Sprenger T Wöller A Zimmer C Behrendt H Ring J Darsow U Tölle TR Cerebral processing of histamine-induced itch using short-term alternating temperature modulation—an FMRI study J. Investig. Dermatol. 2008 128 2 426 433 10.1038/sj.jid.5701002 17657239
Valet, M. et al. Cerebral processing of histamine-induced itch using short-term alternating temperature modulation—an FMRI study. J. Investig. Dermatol. 128(2), 426–433. 10.1038/sj.jid.5701002 (2008).17657239 10.1038/sj.jid.5701002
37. Van De Sand MF Menz MM Sprenger C Büchel C Nocebo-induced modulation of cerebral itch processing—an fMRI study NeuroImage 2017 10.1016/j.neuroimage.2017.10.056 29107770
Van De Sand, M. F., Menz, M. M., Sprenger, C. & Büchel, C. Nocebo-induced modulation of cerebral itch processing—an fMRI study. NeuroImage10.1016/j.neuroimage.2017.10.056 (2017).29107770 10.1016/j.neuroimage.2017.10.056
38. Yosipovitch G Ishiuji Y Patel TS Hicks MI Oshiro Y Kraft RA Winnicki E Coghill RC The brain processing of scratching J. Investig. Dermatol. 2008 128 7 1806 1811 10.1038/jid.2008.3 18239615
Yosipovitch, G. et al. The brain processing of scratching. J. Investig. Dermatol. 128(7), 1806–1811. 10.1038/jid.2008.3 (2008).18239615 10.1038/jid.2008.3
39. Pergola G Danet L Pitel AL Carlesimo GA Segobin S Pariente J Suchan B Mitchell AS Barbeau EJ The regulatory role of the human mediodorsal thalamus Trends Cogn. Sci. 2018 22 11 1011 1025 10.1016/j.tics.2018.08.006 30236489
Pergola, G. et al. The regulatory role of the human mediodorsal thalamus. Trends Cogn. Sci. 22(11), 1011–1025. 10.1016/j.tics.2018.08.006 (2018).30236489 10.1016/j.tics.2018.08.006
40. Mai JK Majtanik M Toward a common terminology for the Thalamus Front. Neuroanatomy 2019 12 1 23 10.3389/fnana.2018.00114
Mai, J. K. & Majtanik, M. Toward a common terminology for the Thalamus. Front. Neuroanatomy 12, 1–23. 10.3389/fnana.2018.00114 (2019).10.3389/fnana.2018.00114
41. Huang X Pu W Li X Greenshaw AJ Dursun SM Xue Z Liu H Liu Z Decreased left putamen and thalamus volume correlates with delusions in first-episode schizophrenia patients Front. Psychiatry 2017 8 1 8 10.3389/fpsyt.2017.00245 28167920
Huang, X. et al. Decreased left putamen and thalamus volume correlates with delusions in first-episode schizophrenia patients. Front. Psychiatry 8, 1–8. 10.3389/fpsyt.2017.00245 (2017).28167920 10.3389/fpsyt.2017.00245
42. Beissner F Meissner K Bar K-J Napadow V The autonomic brain: An activation likelihood estimation meta-analysis for central processing of autonomic function J. Neurosci. 2013 33 25 10503 10511 10.1523/JNEUROSCI.1103-13.2013 23785162
Beissner, F., Meissner, K., Bar, K.-J. & Napadow, V. The autonomic brain: An activation likelihood estimation meta-analysis for central processing of autonomic function. J. Neurosci. 33(25), 10503–10511. 10.1523/JNEUROSCI.1103-13.2013 (2013).23785162 10.1523/JNEUROSCI.1103-13.2013
43. Eilam-Stock T Xu P Cao M Gu X Van Dam NT Anagnostou E Kolevzon A Soorya L Park Y Siller M He Y Hof PR Fan J Abnormal autonomic and associated brain activities during rest in autism spectrum disorder Brain 2014 137 1 153 171 10.1093/brain/awt294 24424916
Eilam-Stock, T. et al. Abnormal autonomic and associated brain activities during rest in autism spectrum disorder. Brain 137(1), 153–171. 10.1093/brain/awt294 (2014).24424916 10.1093/brain/awt294
44. Oaten M Stevenson RJ Williams MA Rich AN Butko M Case TI Moral violations and the experience of disgust and anger Front. Behav. Neurosci. 2018 10.3389/fnbeh.2018.00179 30214400
Oaten, M. et al. Moral violations and the experience of disgust and anger. Front. Behav. Neurosci.10.3389/fnbeh.2018.00179 (2018).30214400 10.3389/fnbeh.2018.00179
45. Seeley WW Menon V Schatzberg AF Keller J Glover GH Kenna H Reiss AL Greicius MD Dissociable intrinsic connectivity networks for salience processing and executive control J. Neurosci. 2007 27 9 2349 2356 10.1523/JNEUROSCI.5587-06.2007 17329432
Seeley, W. W. et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J. Neurosci. 27(9), 2349–2356. 10.1523/JNEUROSCI.5587-06.2007 (2007).17329432 10.1523/JNEUROSCI.5587-06.2007
46. Smith JB Watson GDR Liang Z Liu Y Zhang N Alloway KD A role for the claustrum in salience processing? Front. Neuroanatomy 2019 13 June 1 14 10.3389/fnana.2019.00064
Smith, J. B. et al. A role for the claustrum in salience processing?. Front. Neuroanatomy 13(June), 1–14. 10.3389/fnana.2019.00064 (2019).10.3389/fnana.2019.00064
47. Hampshire A Chamberlain SR Monti MM Duncan J Owen AM The role of the right inferior frontal gyrus: Inhibition and attentional control NeuroImage 2010 50 3 1313 1319 10.1016/j.neuroimage.2009.12.109 20056157
Hampshire, A., Chamberlain, S. R., Monti, M. M., Duncan, J. & Owen, A. M. The role of the right inferior frontal gyrus: Inhibition and attentional control. NeuroImage 50(3), 1313–1319. 10.1016/j.neuroimage.2009.12.109 (2010).20056157 10.1016/j.neuroimage.2009.12.109
48. Swick D Ashley V Turken U Left inferior frontal gyrus is critical for response inhibition BMC Neurosci. 2008 11 1 11 10.1186/1471-2202-9-102
Swick, D., Ashley, V. & Turken, U. Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci. 11, 1–11. 10.1186/1471-2202-9-102 (2008).10.1186/1471-2202-9-102
49. Chang LJ Yarkoni T Khaw MW Sanfey AG Decoding the role of the insula in human cognition: Functional parcellation and large-scale reverse inference Cerebral Cortex 2013 23 3 739 749 10.1093/cercor/bhs065 22437053
Chang, L. J., Yarkoni, T., Khaw, M. W. & Sanfey, A. G. Decoding the role of the insula in human cognition: Functional parcellation and large-scale reverse inference. Cerebral Cortex 23(3), 739–749. 10.1093/cercor/bhs065 (2013).22437053 10.1093/cercor/bhs065
50. Menon V Uddin LQ Saliency, switching, attention and control: A network model of insula function Brain Struct. Funct. 2012 214 5 655 667
Menon, V. & Uddin, L. Q. Saliency, switching, attention and control: A network model of insula function. Brain Struct. Funct. 214(5), 655–667 (2012).
51. Wang Y Ge J Zhang H Wang H Xie X Altruistic behaviors relieve physical pain Proc. Natl. Acad. Sci. U. S. A. 2020 117 2 950 958 10.1073/pnas.1911861117 31888986
Wang, Y., Ge, J., Zhang, H., Wang, H. & Xie, X. Altruistic behaviors relieve physical pain. Proc. Natl. Acad. Sci. U. S. A. 117(2), 950–958. 10.1073/pnas.1911861117 (2020).31888986 10.1073/pnas.1911861117
52. Bostan AC Strick PL The basal ganglia and the cerebellum: Nodes in an integrated network Nat. Rev. Neurosci. 2018 19 6 338 350 10.1038/s41583-018-0002-7 29643480
Bostan, A. C. & Strick, P. L. The basal ganglia and the cerebellum: Nodes in an integrated network. Nat. Rev. Neurosci. 19(6), 338–350. 10.1038/s41583-018-0002-7 (2018).29643480 10.1038/s41583-018-0002-7
53. Hegde AN Mohan S Lath N Lim CCT Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus Radiographics 2011 31 1 10.1148/rg.311105041
Hegde, A. N., Mohan, S., Lath, N. & Lim, C. C. T. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics 31, 1. 10.1148/rg.311105041 (2011).10.1148/rg.311105041
54. Baldo JV Wilkins DP Ogar J Willock S Dronkers NF Role of the precentral gyrus of the insula in complex articulation Cortex 2011 47 7 800 807 10.1016/j.cortex.2010.07.001 20691968
Baldo, J. V., Wilkins, D. P., Ogar, J., Willock, S. & Dronkers, N. F. Role of the precentral gyrus of the insula in complex articulation. Cortex 47(7), 800–807. 10.1016/j.cortex.2010.07.001 (2011).20691968 10.1016/j.cortex.2010.07.001
55. Desmurget M Richard N Harquel S Baraduc P Szathmari A Mottolese C Sirigu A Neural representations of ethologically relevant hand/mouth synergies in the human precentral gyrus Proc. Natl. Acad. Sci. U. S. A. 2014 111 15 5718 5722 10.1073/pnas.1321909111 24706796
Desmurget, M. et al. Neural representations of ethologically relevant hand/mouth synergies in the human precentral gyrus. Proc. Natl. Acad. Sci. U. S. A. 111(15), 5718–5722. 10.1073/pnas.1321909111 (2014).24706796 10.1073/pnas.1321909111
56. Hwang K Bertolero MA Liu WB D’Esposito M The human thalamus is an integrative hub for functional brain networks J. Neurosci. 2017 37 23 5594 5607 10.1523/JNEUROSCI.0067-17.2017 28450543
Hwang, K., Bertolero, M. A., Liu, W. B. & D’Esposito, M. The human thalamus is an integrative hub for functional brain networks. J. Neurosci. 37(23), 5594–5607. 10.1523/JNEUROSCI.0067-17.2017 (2017).28450543 10.1523/JNEUROSCI.0067-17.2017
57. Torgerson CM Irimia A Goh SYM Van Horn JD The DTI connectivity of the human claustrum Hum. Brain Mapp. 2015 36 3 827 838 10.1002/hbm.22667 25339630
Torgerson, C. M., Irimia, A., Goh, S. Y. M. & Van Horn, J. D. The DTI connectivity of the human claustrum. Hum. Brain Mapp. 36(3), 827–838. 10.1002/hbm.22667 (2015).25339630 10.1002/hbm.22667
58. Harrington DL Zimbelman JL Hinton SC Rao SM Neural modulation of temporal encoding, maintenance, and decision processes Cerebral Cortex 2010 20 6 1274 1285 10.1093/cercor/bhp194 19778958
Harrington, D. L., Zimbelman, J. L., Hinton, S. C. & Rao, S. M. Neural modulation of temporal encoding, maintenance, and decision processes. Cerebral Cortex 20(6), 1274–1285. 10.1093/cercor/bhp194 (2010).19778958 10.1093/cercor/bhp194
59. Yin D Liu W Zeljic K Wang Z Lv Q Fan M Cheng W Wang Z Dissociable changes of frontal and parietal cortices in inherent functional flexibility across the human life span J. Neurosci. 2016 36 39 10060 10074 10.1523/JNEUROSCI.1476-16.2016 27683903
Yin, D. et al. Dissociable changes of frontal and parietal cortices in inherent functional flexibility across the human life span. J. Neurosci. 36(39), 10060–10074. 10.1523/JNEUROSCI.1476-16.2016 (2016).27683903 10.1523/JNEUROSCI.1476-16.2016
60. Zhang S Tsai SJ Hu S Xu J Chao HH Calhoun VD Li CSR Independent component analysis of functional networks for response inhibition: Inter-subject variation in stop signal reaction time Hum. Brain Mapp. 2015 36 9 3289 3302 10.1002/hbm.22819 26089095
Zhang, S. et al. Independent component analysis of functional networks for response inhibition: Inter-subject variation in stop signal reaction time. Hum. Brain Mapp. 36(9), 3289–3302. 10.1002/hbm.22819 (2015).26089095 10.1002/hbm.22819
61. Amodio DM Frith CD Meeting of minds: The medial frontal cortex and social cognition Nat. Rev. Neurosci. 2006 7 April 268 277 10.1038/nrn1884 16552413
Amodio, D. M. & Frith, C. D. Meeting of minds: The medial frontal cortex and social cognition. Nat. Rev. Neurosci. 7(April), 268–277. 10.1038/nrn1884 (2006).16552413 10.1038/nrn1884
62. Bolam JP Ellender TJ Histamine and the striatum Neuropharmacology 2016 106 74 84 10.1016/j.neuropharm.2015.08.013 26275849
Bolam, J. P. & Ellender, T. J. Histamine and the striatum. Neuropharmacology 106, 74–84. 10.1016/j.neuropharm.2015.08.013 (2016).26275849 10.1016/j.neuropharm.2015.08.013
63. Rapanelli M Frick L Bito H Pittenger C Histamine modulation of the basal ganglia circuitry in the development of pathological grooming Proc. Natl. Acad. Sci. U. S. A. 2017 114 25 6599 6604 10.1073/pnas.1704547114 28584117
Rapanelli, M., Frick, L., Bito, H. & Pittenger, C. Histamine modulation of the basal ganglia circuitry in the development of pathological grooming. Proc. Natl. Acad. Sci. U. S. A. 114(25), 6599–6604. 10.1073/pnas.1704547114 (2017).28584117 10.1073/pnas.1704547114
64. Papoiu ADP Tey HL Coghill RC Wang H Yosipovitch G Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch PLoS ONE 2011 6 3 1 5 10.1371/journal.pone.0017786
Papoiu, A. D. P., Tey, H. L., Coghill, R. C., Wang, H. & Yosipovitch, G. Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch. PLoS ONE 6(3), 1–5. 10.1371/journal.pone.0017786 (2011).10.1371/journal.pone.0017786
65. Fama R Sullivan EV Thalamic structures and associated cognitive functions: Relations with age and aging Rosemary Neurosci. Biobehav. Rev. 2015 54 29 378 10.1016/j.neubiorev.2015.03.008 25862940
Fama, R. & Sullivan, E. V. Thalamic structures and associated cognitive functions: Relations with age and aging Rosemary. Neurosci. Biobehav. Rev. 54, 29–378. 10.1016/j.neubiorev.2015.03.008 (2015).25862940 10.1016/j.neubiorev.2015.03.008
66. Goll Y Atlan G Citri A Attention: The claustrum Trends Neurosci. 2015 38 8 486 495 10.1016/j.tins.2015.05.006 26116988
Goll, Y., Atlan, G. & Citri, A. Attention: The claustrum. Trends Neurosci. 38(8), 486–495. 10.1016/j.tins.2015.05.006 (2015).26116988 10.1016/j.tins.2015.05.006
67. Kim JJ Kent KM Cunnington R Gilbert P Kirby JN Attachment styles modulate neural markers of threat and imagery when engaging in self-criticism Sci. Rep. 2020 10 13776 1 10 10.1038/s41598-020-70772-x 31913322
Kim, J. J., Kent, K. M., Cunnington, R., Gilbert, P. & Kirby, J. N. Attachment styles modulate neural markers of threat and imagery when engaging in self-criticism. Sci. Rep. 10(13776), 1–10. 10.1038/s41598-020-70772-x (2020).31913322 10.1038/s41598-020-70772-x
68. Kim JJ Doty JR Cunnington R Kirby JN Does self-reassurance reduce neural and self-report reactivity to negative life events? Front. Psychol. 2021 12 785 10.3389/fpsyg.2021.658118
Kim, J. J., Doty, J. R., Cunnington, R. & Kirby, J. N. Does self-reassurance reduce neural and self-report reactivity to negative life events?. Front. Psychol. 12, 785. 10.3389/fpsyg.2021.658118 (2021).10.3389/fpsyg.2021.658118
69. Molenberghs P Johnson H Henry JD Mattingley JB Understanding the minds of others: A neuroimaging meta-analysis Neurosci. Biobehav. Rev. 2016 10.1016/j.neubiorev.2016.03.020 27073047
Molenberghs, P., Johnson, H., Henry, J. D. & Mattingley, J. B. Understanding the minds of others: A neuroimaging meta-analysis. Neurosci. Biobehav. Rev.10.1016/j.neubiorev.2016.03.020 (2016).27073047 10.1016/j.neubiorev.2016.03.020
70. Wang P Zhu X Qi Z Huang S Li H Neural basis of enhanced executive function in older video game players: An fMRI study Front. Aging Neurosci. 2017 2017 9 10.3389/fnagi.2017.00382
Wang, P., Zhu, X., Qi, Z., Huang, S. & Li, H. Neural basis of enhanced executive function in older video game players: An fMRI study. Front. Aging Neurosci. 2017, 9. 10.3389/fnagi.2017.00382 (2017).10.3389/fnagi.2017.00382
71. Zhao Q Functional segregation of executive control network and frontoparietal network in Alzheimer’s disease Cortex 2019 120 36 42 10.1016/j.cortex.2019.04.026 31228791
Zhao, Q. et al. Functional segregation of executive control network and frontoparietal network in Alzheimer’s disease. Cortex 120, 36–42. 10.1016/j.cortex.2019.04.026 (2019).31228791 10.1016/j.cortex.2019.04.026
72. Sasabayashi D Takayanagi Y Takahashi T Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes Transl. Psychiatry 2021 11 396 10.1038/s41398-021-01516-2 34282119
Sasabayashi, D. et al. Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes. Transl. Psychiatry 11, 396. 10.1038/s41398-021-01516-2 (2021).34282119 10.1038/s41398-021-01516-2
73. Hsieh JC Hagermark O Stahle-Backdahl M Ericson K Eriksson L Stone-Elander S Ingvar M Urge to scratch represented in the human cerebral cortex during itch J. Neurophysiol. 1994 72 6 3004 3008 10.1152/jn.1994.72.6.3004 7897505
Hsieh, J. C. et al. Urge to scratch represented in the human cerebral cortex during itch. J. Neurophysiol. 72(6), 3004–3008. 10.1152/jn.1994.72.6.3004 (1994).7897505 10.1152/jn.1994.72.6.3004
74. Melzack R Wall PO The Challenge of Pain 1988 2 Penguin Books
Melzack, R. & Wall, P. O. The Challenge of Pain 2nd edn. (Penguin Books, 1988).
75. Melzack R Pain and the neuromatrix in the brain J. Dental Educ. 2001 65 12 1378 1382 10.1002/j.0022-0337.2001.65.12.tb03497.x
Melzack, R. Pain and the neuromatrix in the brain. J. Dental Educ. 65(12), 1378–1382 (2001).10.1002/j.0022-0337.2001.65.12.tb03497.x
76. Butler DS Moseley L Explain Pain 2003 NOI Group Publications
Butler, D. S. & Moseley, L. Explain Pain (NOI Group Publications, 2003).
77. Thorn B Cognitive Therapy for Chronic Pain: A Step-by-Step Guide 2004 2 The Guilford Press
Thorn, B. Cognitive Therapy for Chronic Pain: A Step-by-Step Guide 2nd edn. (The Guilford Press, 2004).
78. Day MA Mindfulness-Based Cognitive Therapy for Chronic Pain: A Clinical Manual and Guide 2017 Wiley
Day, M. A. Mindfulness-Based Cognitive Therapy for Chronic Pain: A Clinical Manual and Guide (Wiley, 2017).
79. Seminowicz DA Shpaner M Keaser ML Krauthamer GM Mantegna J Dumas JA Newhouse PA Filippi CG Keefe FJ Naylor MR Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain J. Pain 2013 14 12 1573 1584 10.1016/j.jpain.2013.07.020 24135432
Seminowicz, D. A. et al. Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain. J. Pain 14(12), 1573–1584 (2013).24135432 10.1016/j.jpain.2013.07.020
80. Ashar YK Gordon A Schubiner Effect of pain reprocessing therapy vs placebo and usual care for patients with chronic back pain: A randomized clinical trial JAMA Psychiatry 2022 79 1 13 23 10.1001/jamapsychiatry.2021.2669 34586357
Ashar, Y. K. et al. Effect of pain reprocessing therapy vs placebo and usual care for patients with chronic back pain: A randomized clinical trial. JAMA Psychiatry 79(1), 13–23. 10.1001/jamapsychiatry.2021.2669 (2022).34586357 10.1001/jamapsychiatry.2021.2669
81. Arkwright PD Stafford JC Sharma V Atopic dermatitis in children J. Allergy Clin. Immunol. Pract. 2014 2 4 388 395 10.1016/j.jaip.2014.01.016 25017525
Arkwright, P. D., Stafford, J. C. & Sharma, V. Atopic dermatitis in children. J. Allergy Clin. Immunol. Pract. 2(4), 388–395. 10.1016/j.jaip.2014.01.016 (2014).25017525 10.1016/j.jaip.2014.01.016
82. Chida Y Steptoe A Hirakawa N Sudo N Kubo C The effects of psychological intervention on atopic dermatitis: A systematic review and meta-analysis Int. Arch. Allergy Immunol. 2007 144 1 1 9 10.1159/000101940 17449959
Chida, Y., Steptoe, A., Hirakawa, N., Sudo, N. & Kubo, C. The effects of psychological intervention on atopic dermatitis: A systematic review and meta-analysis. Int. Arch. Allergy Immunol. 144(1), 1–9. 10.1159/000101940 (2007).17449959 10.1159/000101940
83. Hedman-Lagerlöf E Bergman A Lindefors N Bradley M Exposure-based cognitive behavior therapy for atopic dermatitis: An open trial Cogn. Behav. Therapy 2019 48 4 300 310 10.1080/16506073.2018.1504320
Hedman-Lagerlöf, E., Bergman, A., Lindefors, N. & Bradley, M. Exposure-based cognitive behavior therapy for atopic dermatitis: An open trial. Cogn. Behav. Therapy 48(4), 300–310. 10.1080/16506073.2018.1504320 (2019).10.1080/16506073.2018.1504320
84. Wittkowski A Richards HL How beneficial is cognitive behaviour therapy in the treatment of atopic dermatitis? A single-case study Psychol. Health Med. 2007 12 4 445 449 10.1080/13548500601109268 17620208
Wittkowski, A. & Richards, H. L. How beneficial is cognitive behaviour therapy in the treatment of atopic dermatitis? A single-case study. Psychol. Health Med. 12(4), 445–449. 10.1080/13548500601109268 (2007).17620208 10.1080/13548500601109268
85. Farb, N. A. S., Anderson, A. K., Irving, J. A., & Segal, Z. V. Mindfulness interventions and emotion regulation. In Handbook of emotion regulation, 2nd ed 548–567 (The Guilford Press, 2014).
86. Chambers R Gullone E Allen NB Mindful emotion regulation: An integrative review Clin. Psychol. Rev. 2009 29 6 560 572 10.1016/j.cpr.2009.06.005 19632752
Chambers, R., Gullone, E. & Allen, N. B. Mindful emotion regulation: An integrative review. Clin. Psychol. Rev. 29(6), 560–572. 10.1016/j.cpr.2009.06.005 (2009).19632752 10.1016/j.cpr.2009.06.005
87. Kim JJ Parker SL Doty JR Cunnington R Gilbert P Kirby JN Neurophysiological and behavioural markers of compassion Sci. Rep. 2020 10 745 10.1038/s41598-020-63846-3 31937886
Kim, J. J. et al. Neurophysiological and behavioural markers of compassion. Sci. Rep. 10, 745. 10.1038/s41598-020-63846-3 (2020).31937886 10.1038/s41598-020-63846-3
88. Kim JJ Cunnington R Kirby JN The neurophysiological basis of compassion: An fMRI meta-analysis of compassion and its related neural processes Neurosci. Biobehav. Rev. 2020 108 112 123 10.1016/j.neubiorev.2019.10.023 31697955
Kim, J. J., Cunnington, R. & Kirby, J. N. The neurophysiological basis of compassion: An fMRI meta-analysis of compassion and its related neural processes. Neurosci. Biobehav. Rev. 108, 112–123. 10.1016/j.neubiorev.2019.10.023 (2020).31697955 10.1016/j.neubiorev.2019.10.023
89. Dalgard FJ Svensson Å Halvorsen JA Gieler U Schut C Tomas-Aragones L Lien L Poot F Jemec GBE Misery L Szabo C Linder D Sampogna F van Koulil SS Balieva F Szepietowski JC Lvov A Marron SE Altunay IK Kupfer J Itch and mental health in dermatological patients across Europe: A cross-sectional study in 13 countries J. Investig. Dermatol. 2020 140 3 568 573 10.1016/j.jid.2019.05.034 31491369
Dalgard, F. J. et al. Itch and mental health in dermatological patients across Europe: A cross-sectional study in 13 countries. J. Investig. Dermatol. 140(3), 568–573. 10.1016/j.jid.2019.05.034 (2020).31491369 10.1016/j.jid.2019.05.034
90. Misery L Dutray S Chastaing M Schollhammer M Consoli SG Consoli SM Psychogenic itch Transl. Psychiatry 2018 8 1 896 10.1038/s41398-018-0097-7
Misery, L. et al. Psychogenic itch. Transl. Psychiatry 8(1), 896. 10.1038/s41398-018-0097-7 (2018).10.1038/s41398-018-0097-7
91. Weisshaar E Epidemiology of itch Curr. Probl. Dermatol. 2016 50 5 10 10.1159/000446010 27578064
Weisshaar, E. Epidemiology of itch. Curr. Probl. Dermatol. 50, 5–10. 10.1159/000446010 (2016).27578064 10.1159/000446010
92. Lee HG Stull C Yosipovitch G Psychiatric disorders and pruritus Clin. Dermatol. 2017 35 3 273 280 10.1016/j.clindermatol.2017.01.008 28511824
Lee, H. G., Stull, C. & Yosipovitch, G. Psychiatric disorders and pruritus. Clin. Dermatol. 35(3), 273–280. 10.1016/j.clindermatol.2017.01.008 (2017).28511824 10.1016/j.clindermatol.2017.01.008
93. Eickhoff SB Laird AR Grefkes C Wang LE Zilles K Fox PT Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: A random-effects approach based on empirical estimates of spatial uncertainty Hum. Brain Mapp. 2009 30 9 2907 2926 10.1002/hbm.20718 19172646
Eickhoff, S. B. et al. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: A random-effects approach based on empirical estimates of spatial uncertainty. Hum. Brain Mapp. 30(9), 2907–2926. 10.1002/hbm.20718 (2009).19172646 10.1002/hbm.20718
94. Enge A Friederici AD Skeide MA A meta-analysis of fMRI studies of language comprehension in children NeuroImage 2020 215 April 116858 10.1016/j.neuroimage.2020.116858 32304886
Enge, A., Friederici, A. D. & Skeide, M. A. A meta-analysis of fMRI studies of language comprehension in children. NeuroImage 215(April), 116858. 10.1016/j.neuroimage.2020.116858 (2020).32304886 10.1016/j.neuroimage.2020.116858
95. Eickhoff SB Nichols TE Laird AR Hoffstaedter F Amunts K Fox PT Bzdok D Eickhoff CR Behavior, sensitivity, and power of activation likelihood estimation characterized by massive empirical simulation NeuroImage 2016 137 70 85 10.1016/j.neuroimage.2016.04.072 27179606
Eickhoff, S. B. et al. Behavior, sensitivity, and power of activation likelihood estimation characterized by massive empirical simulation. NeuroImage 137, 70–85. 10.1016/j.neuroimage.2016.04.072 (2016).27179606 10.1016/j.neuroimage.2016.04.072
96. Woo CW Krishnan A Wager TD Cluster-extent based thresholding in fMRI analyses Neuroimage 2012 100 2 130 134 10.1016/j.neuroimage.2013.12.058.Cluster-extent
Woo, C. W., Krishnan, A. & Wager, T. D. Cluster-extent based thresholding in fMRI analyses. Neuroimage 100(2), 130–134. 10.1016/j.neuroimage.2013.12.058.Cluster-extent (2012).10.1016/j.neuroimage.2013.12.058.Cluster-extent
